The discovery of a molecule that interferes with a component of the insulin-signaling pathway provides a target for drug development.
No takes yet. Share an insight, caveat, or question.
Alan R. Saltiel (2003) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: